Clinicopathological Study of 18 Cases of Inflammatory Myofibroblastic Tumors with Reference to ALK-1 Expression: 5-Year Experience in a Tertiary Care Center
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Inflammatory myofibroblastic tumor is a histopathologically distinctive neoplasm of children and young adults. According to World Health Organization (WHO) classification, inflammatory myofibroblastic tumor is an intermediate-grade tumor, with potential for recurrence and rare metastasis. There are no definite histopathologic, molecular, or cytogenetic features to predict malignant transformation, recurrence, or metastasis. Methods: A 5-year retrospective study of histopathologically diagnosed inflammatory myofibroblastic tumors of various anatomic sites was conducted to correlate anaplastic lymphoma kinase-1 (ALK-1) expression with histological atypia, multicentric origin of tumor, recurrence, and metastasis. Clinical details of all the cases were noted from the clinical work station. Immunohistochemical stains for ALK-1 and other antibodies were performed. Statistical analysis was done using Fisher exact test. Results: A total of 18 cases of inflammatory myofibroblastic tumors were found during the study period, of which 14 were classical. The female-male ratio was 1:1 and the mean age was 23.8 years. Histologically atypical (four cases) and multifocal tumors (three cases, multicentric in origin) were noted. Recurrence was noted in 30% of ALK-1 positive and 37.5% of ALK-1 negative cases, whereas metastasis to the lung, liver, and pelvic bone was noted in the ALK-1 positive group only. Conclusions: Overall, ALK-1 protein was expressed in 55.6% of inflammatory myofibroblastic tumors. There was no statistically significant correlation between ALK-1 expression, tumor type, recurrence and metastasis. However, ALK-1 immunohistochemistry is a useful diagnostic aid in the appropriate clinical and histomorphologic context.
Abstract
Background: Inflammatory myofibroblastic tumor is a histopathologically distinctive neoplasm of children and young adults. According to World Health Organization (WHO) classification, inflammatory myofibroblastic tumor is an intermediate-grade tumor, with potential for recurrence and rare metastasis. There are no definite histopathologic, molecular, or cytogenetic features to predict malignant transformation, recurrence, or metastasis. Methods: A 5-year retrospective study of histopathologically diagnosed inflammatory myofibroblastic tumors of various anatomic sites was conducted to correlate anaplastic lymphoma kinase-1 (ALK-1) expression with histological atypia, multicentric origin of tumor, recurrence, and metastasis. Clinical details of all the cases were noted from the clinical work station. Immunohistochemical stains for ALK-1 and other antibodies were performed. Statistical analysis was done using Fisher exact test. Results: A total of 18 cases of inflammatory myofibroblastic tumors were found during the study period, of which 14 were classical. The female-male ratio was 1:1 and the mean age was 23.8 years. Histologically atypical (four cases) and multifocal tumors (three cases, multicentric in origin) were noted. Recurrence was noted in 30% of ALK-1 positive and 37.5% of ALK-1 negative cases, whereas metastasis to the lung, liver, and pelvic bone was noted in the ALK-1 positive group only. Conclusions: Overall, ALK-1 protein was expressed in 55.6% of inflammatory myofibroblastic tumors. There was no statistically significant correlation between ALK-1 expression, tumor type, recurrence and metastasis. However, ALK-1 immunohistochemistry is a useful diagnostic aid in the appropriate clinical and histomorphologic context.
참고문헌 (19)
- Ufuk F, "Inflammatory myofibroblastic tumor of the lung: unusual imaging findings of three cases", Pol J Radiol, 80, pp.479~482 (2015)
- Umiker WO, "Postinflammatory tumors of the lung: report of four cases simulating xanthoma, fibroma or plasma cell tumor", J Thorac Surg, 28, pp.55~63 (1954)
- Fletcher CD, "WHO classification of tumours of soft tissue and bone", pp.83~84 (2013), IARC Press
- Marino-Enriquez A, "Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK", Am J Surg Pathol, 35, pp.135~144 (2011)
- Li J, "Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement : a report of two cases and literature review", Diagn Pathol, 8, pp.147~ (2013)
- Savvidou OD, "Inflammatory myofibroblastic tumor of the thigh : presentation of a rare case and review of the literature", Case Rep Orthop, 2015, pp.814241~ (2015)
- Coffin CM, "Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases", Am J Surg Pathol, 31, pp.509~520 (2007)
- Tao YL, "Inflammatory myofibroblastic tumor successfully treated with chemotherapy and nonsteroidals : a case report", World J Gastroenterol, 18, pp.7100~7103 (2012)
- Wang Z, "Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center", Pediatr Surg Int, 32, pp.239~243 (2016)
- Karnak I, "Inflammatory myofibroblastic tumor in children : diagnosis and treatment", J Pediatr Surg, 36, pp.908~912 (2001)
- Fragoso AC, "Abdominal inflammatory myofibroblastic tumor a clinicopathologic study with reappraisal of biologic behavior", J Pediatr Surg, 46, pp.2076~2082 (2011)
- Hussong JW, "Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors", Mod Pathol, 12, pp.279~286 (1999)
- Jiang YH, "Comparison of the clinical and immunohistochemical features, including anaplastic lymphoma kinase (ALK) and p53, in inflammatory myofibroblastic tumours", J Int Med Res, 37, pp.867~877 (2009)
- Janik JS, "Recurrent inflammatory pseudotumors in children", J Pediatr Surg, 38, pp.1491~1495 (2003)
- Chaudhary P, "Mesenteric inflammatory myofibroblastic tumors", Ann Gastroenterol, 28, pp.49~54 (2015)
- Ramotar H, "The great mimicker : a rare case of head and neck inflammatory pseudotumour in the presence of human immunodeficiency virus", J Laryngol Otol, 130, pp.107~110 (2016)
- Li XQ, "Expression of anaplastic lymphoma kinase in soft tissue tumors : an immunohistochemical and molecular study of 249 cases", Hum Pathol, 35, pp.711~721 (2004)
- Jacob SV, "An unusual case of systemic inflammatory myofibroblastic tumor with successful treatment with ALK-inhibitor", Case Rep Pathol, 2014, pp.470340~ (2014)
- Butrynski JE, "Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor", N Engl J Med, 363, pp.1727~1733 (2010)